Dpw holdings' announces that the journal of alzheimer's disease highlights milestone research (al002) licensed by alzamend neuro® from the university of south florida

New immunomodulatory therapeutic vaccine developed by usf's dr. chuanhai cao that targets oligomeric amyloid-Β could be step towards halting alzheimer's disease progression new immunomodulatory therapeutic vaccine developed by usf's dr. chuanhai cao that targets oligomeric amyloid-Β could be step towards halting alzheimer's disease progression
DPW Ratings Summary
DPW Quant Ranking